#AstraZeneca is likely to run an additional global #trial to assess the efficacy of its #Covid-19 #vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over the results of its late-stage study.
Subscribe to France 24 now:
FRANCE 24 live news stream: all the latest news 24/7
Visit our website:
Subscribe to our YouTube channel:
Like us on Facebook:
Follow us on Twitter:
Tweets by France24_en